Abstract
The aim of the present study was to investigate the clinical characteristics, treatments and outcomes of patients with primary suprasellar germinoma, a rare malignant brain tumor. In the present study, the medical data of 15 cases of primary suprasellar germinoma were retrospectively reviewed. The basic clinical characteristics, primary symptoms, admission period, surgical treatment, radiotherapy and chemotherapy, and follow-up were analyzed. There were 6 female (40%) and 9 male (60%) patients, with a mean age of 19.6 ± 7.4 years (age range, 9–39 years). The mean admission period was 17.0 ± 19.0 months (range, 0.5–260 months), and the mean follow-up period was 28.8 ± 21.5 months (range, 4–70 months). The primary complaints were polydipsia and polyuria (66.7%) and visual impairment (53.3%); 2 cases (13.3%) were affected in both the suprasellar and the pineal regions. In all 15 cases, a diagnosis of germinoma was histopathologically confirmed by craniotomy or biopsy, though gross total resection was only achieved in 1 patient. No instances of surgical mortality were observed. After surgery, all patients underwent radiotherapy and chemotherapy, and all recovered well following discharge. During follow-up, symptoms were markedly relieved and a reduction in tumor size was observed in all cases. However, 1 patient died 4 months post-surgery due to progressive disturbance of consciousness and severe pulmonary infection. In conclusion, primary suprasellar germinoma is a rare malignant brain tumor, of which progressive polydipsia and polyuria, and visual impairment are the primary symptoms. Thickening of the pituitary stalk may be the only initial imaging manifestation. Craniotomy for partial resection or endoscopic biopsy is strongly recommended to confirm histological diagnosis. Whole ventricular radiotherapy plus local enhanced radiotherapy, or combined radiotherapy and chemotherapy, are effective at reducing tumor size and relieving symptoms. Prognosis is favorable for most patients with primary suprasellar germinoma, though endocrine deficiencies should be managed appropriately.